In this photo released by the Ishaqbini Community Conservancy, a male giraffe with a rare genetic trait called leucism that causes a white color is darted with a tranquilizer in order to fit a GPS tracking device, seen from a helicopter in the Ishaqbini Community Conservancy in Kenya Sunday, Nov. 8, 2020. (Ishaqbini Community Conservancy via AP)
The only known white giraffe in the world has been fitted with a GPS tracking device to help protect it from poachers as it grazes in Kenya. But despite its singular status, the lonely male doesn't have a name.
The white giraffe now stands alone after a female and her calf were killed by poachers in March, the Ishaqbini Hirola Community Conservancy said in a statement Tuesday.
A rare genetic trait called leucism causes the white color, and it makes the one surviving giraffe stand out dangerously for poachers in the arid savannah near the Somalia border.
Now the GPS tracking device, attached to one of the giraffe’s horns, will ping every hour to alert wildlife rangers to its location.
The conservancy has thanked the Kenya Wildlife Service along with the Northern Rangelands Trust and Save Giraffes Now for the help.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
